Advertisement
U.S. Markets open in 8 hrs 52 mins
S&P Futures
5,968.50 +10.25 (+0.17%) Dow Futures
44,011.00 +110.00 (+0.25%) Nasdaq Futures
20,937.00 +43.00 (+0.21%) Russell 2000 Futures
2,412.30 +6.50 (+0.27%) Crude Oil
72.03 +0.34 (+0.47%) Gold
2,665.10 -11.20 (-0.42%)
Galapagos NV (GLPG.AS)
Amsterdam - Amsterdam Delayed Price. Currency in EUR
Follow
At close: 05:35PM CET
| Previous Close | 24.70 |
| Open | 25.34 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 24.70 - 25.34 |
| 52 Week Range | 22.00 - 39.00 |
| Volume | |
| Avg. Volume | 108,524 |
| Market Cap | 1.665B |
| Beta (5Y Monthly) | 0.09 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.92 |
| Earnings Date | Oct 30, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 39.00 |
GlobeNewswireGalapagos to Present Results of Pioneering Innovation in Cancer Cell Therapy at ASH 2024
New Phase 1/2 data support the potential of our CAR T-cell therapy candidates, GLPG5101 and GLPG5201, in addressing unmet needs for patients with poor prognoses. Our innovative decentralized cell therapy manufacturing platform delivers fresh, fit cells within a median vein-to-vein time of seven days, with potentially encouraging patient outcomes. Three abstracts, including one oral presentation for GLPG5101 in relapsed/refractory non-Hodgkin lymphoma, and a company showcase, will spotlight our c
Simply Wall St.Galapagos Third Quarter 2024 Earnings: €0.74 loss per share (vs €0.39 profit in 3Q 2023)
Galapagos ( AMS:GLPG ) Third Quarter 2024 Results Key Financial Results Revenue: €59.8m (down 50% from 3Q 2023). Net...
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.